Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation

Brain Research

Volumn 1058, Issue 1-2, 2005, Pages 183-188

  Peña Altamira, Emiliano ^a   Crochemore, Christophe ^a   Virgili, Marco ^a   Contestabile, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cholinergic neuron; GABAergic neuron; Neurodegeneration; Neuroprotection; Rat; Transgenic mice

Indexed keywords

CREATINE; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL POPULATION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; ENZYME ACTIVATION; FOREBRAIN; GABAERGIC SYSTEM; LIFESPAN; MALE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BASAL NUCLEUS OF MEYNERT; BIOLOGICAL MARKERS; BRAIN; CELL DEATH; CHOLINERGIC FIBERS; CORPUS STRIATUM; CREATINE; DIETARY SUPPLEMENTS; GLUTAMATE DECARBOXYLASE; IBOTENIC ACID; MALE; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RATS, WISTAR; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

EID: 26244434540     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.07.011     Document Type: Article

References (38)

1. M.F. Beal, E. Brouillet, B. Jenkins, R. Henshaw, B. Rosen, and B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1150
2. Y.M. Bordelon, M.F. Chesselet, D. Nelson, F. Welsh, and M. Erecinska Energetic dysfunction in quinolinic acid-lesioned rat striatum J. Neurochem. 69 1997 1629 1639
3. A. Cameron Ellis, and J. Rosenfield The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders CNS Drugs 18 2004 967 980
4. F. Casamenti, C. Prosperi, L. Scali, G. Giovannelli, and G. Pepeu Morphological, biochemical and behavioral changes induced by neurotoxic and inflammatory insults to the nucleus basalis Int. J. Dev. Neurosci. 16 1998 705 714
5. E. Ciani, I. Baldinotti, and A. Contestabile Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury Brain Res. Bull. 56 2001 29 35
6. A. Contestabile, E. Ciani, and A. Contestabile Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity Brain Res. 1002 2004 162 166
7. C. Crochemore, E. Peña-Altamira, M. Virgili, B. Monti, and A. Contestabile Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice Neurochem. Int. 46 2005 357 368
8. A. Dedeoglu, J.K. Kubilus, L. Yang, K.L. Ferrante, F.M. Hersch, M.F. Beal, and R.J. Ferrante Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice J. Neurochem. 85 2003 1359 1367
9. W. Derave, L. Van Den Bosch, G. Lemmens, B.O. Eijnde, W. Robberecht, and P. Hespel Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment Neurobiol. Dis. 13 2003 264 272
10. V.E. Drory, and D. Gross No effect of creatine on respiratory distress in amyotrophic lateral sclerosis Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 3 2002 43 46
11. F. Facchinetti, M. Sasaki, F.B. Cutting, P. Zhal, J.E. Macdonald, D. Reif, M.F. Beals, P.L. Huang, T.M. Dawson, M.E. Gurney, and V.L. Dawson Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis Neuroscience 90 1999 1483 1492
12. F. Fonnum A rapid radiochemical method for the determination of choline acetyltransferase J. Neurochem. 24 1975 407 409
13. F. Fonnum, I. Walaas, and E. Iversen Localization of GABAergic, cholinergic and aminergic structures in the mesolimbic system J. Neurochem. 29 1977 211 230
14. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
15. J.G. Greene, R.H. Porter, R.V. Eller, and J.T. Greenamyre Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum J. Neurochem. 61 1993 1151 1154
16. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.X. Deng, W. Chen, P. Zhai, R.L. Sufit, and T. Siddique Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775
17. O.N. Hausmann, K. Fouad, T. Walliman, and M.E. Schwab Protective effects of oral creatine supplementation on spinal cord injury in rats Spinal Cord 40 2002 449 456
18. O.S. Ipsiroglu, C. Stromberger, J. Ilas, H. Hoger, A. Muhl, and S. Stockler-Ipsiroglu Changes of tissue creatine concentrations upon oral supplementation of creatine monohydrate in various animal species Life Sci. 69 2001 1805 1815
19. P. Klivenyi, R.J. Ferrante, R.T. Matthews, M.B. Bogdanov, A.M. Klein, O.A. Andreassen, G. Mueller, M. Wermer, R. Kaddurah-Daouk, and M.F. Beal Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nat. Med. 5 1999 347 350
20. P. Klivenyi, N.Y. Calingasan, A. Starkov, I.G. Stravovskaya, B.S. Kristal, L. Yang, B. Wieringa, and M.F. Beal Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase Neurobiol. Dis. 15 2004 610 617
21. J.M. Lawler, W.S. Barnes, G. Wu, W. Song, and S. Demaree Direct antioxidant properties of creatine Biochem. Biophys. Res. Commun. 290 2002 47 52
22. O.H. Lowry, R.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
23. C. Malcon, R. Kaddurah-Dauk, and M.F. Beal Neuroprotective effects of creatine administration against NMDA and malonate toxicity Brain Res. 860 2000 195 198
24. R.T. Matthews, L. Yang, B.G. Jenkins, R.J. Ferrante, B.R. Rosen, R. Kaddurah-Dauk, and M.F. Beal Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington disease J. Neurosci. 18 1998 156 163
25. R.T. Matthews, R.J. Ferrante, P. Klivenyi, L. Yang, A.M. Klein, G. Mueller, R. Kaddurah-Daouk, and M.F. Beal Creatine and cyclocreatine attenuate MPTP neurotoxicity Exp. Neurol. 157 1999 142 149
26. M.M. Mesulam, E.J. Mufson, B.H. Wainer, and A.I. Levey Central cholinergic pathways in the rat: an overview based on an alternative nomenclature Neuroscience 10 1983 1185 1201
27. E. O'Gorman, G. Beutner, M. Dolder, A.P. Korektsi, D. Brdiczka, and T. Walliman The role of creatine kinase in inhibition of mitochondrial permeability transition FEBS Lett. 414 1997 253 257
28. J. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1982 Academic Press Sidney
29. J.M. Shefner, M.E. Cudkowicz, D. Schoenfeld, T. Conrad, J. Taft, M. Chilton, L. Urbinelli, M. Qureshi, H. Zhang, A. Pestronk, J. Caress, P. Donofrio, E. Sorenson, W. Bradley, C. Lomen-Hoerth, E. Pioro, K. Rezania, M. Ross, R. Pascuzzi, T. Heiman-Patterson, R. Tandan, H. Mitsumoto, J. Rothstein, T. Smith-Palmer, D. MacDonald, and D. Burke NEALS Consortium. A clinical trial of creatine in ALS Neurology 63 2004 1656 1661
30. A.K. Stout, H.M. Raphael, B.I. Kanterewicz, E. Klann, and I.J. Reynolds Glutamate-induced neuron death requires mitochondrial calcium uptake Nat. Neurosci. 1 1998 366 373
31. P.G. Sullivan, J.D. Geiger, M.P. Mattson, and S.W. Scheff Dietary supplement creatine protects against traumatic brain injury Ann. Neurol. 48 2000 723 729
32. K. Tsuji, Y. Nakamura, T. Ogata, T. Shibata, and K. Kataoka Rapid decrease in ATP content without recovery phase during glutamate-induced cell death in cultured spinal neurons Brain Res. 662 1994 289 292
33. M. Virgili, P. Migani, A. Contestabile, and O. Barnabei Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers Neuropharmacology 31 1992 469 474
34. S. Wendt, A. Dedeoglu, O. Speer, T. Wallimann, M.F. Beal, and O.A. Andreassen Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice Free Radic. Biol. Med. 32 2002 920 926
35. N.J. Woolf Cholinergic systems in mammalian brain and spinal cord Prog. Neurobiol. 37 1991 475 524
36. M. Wyss, and R. Kaddurah-Daouk Creatine and creatine metabolism Physiol. Rev. 2000 1107 1213
37. W. Zhang, M. Narayanan, and R.M. Friedlander Additive neuroprotective effects of mynocycline with creatine in a mouse model of ALS Ann. Neurol. 53 2003 267 270
38. S. Zhu, M. Li, B.E. Figueroa, A. Liu, I.G. Stavrovskaya, P. Pasinelli, M.F. Beal, R.H. Brown Jr., B.S. Kristal, R.J. Ferrante, and R.M. Friedlander Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice J. Neurosci. 24 2004 5909 5912